GEIST:UPC Searchengine

ORD_38807/2024

Abbott Diabetes Care Inc. v. Dexcom Deutschland GmbH, Dexcom International Limited , Dexcom Inc.

Datum
2024-08-09
Kammer
Munich (DE) Local Division
Verfahrensart
Application RoP262A
Sprache
EN

Metadaten

Fall-IDORD_38807-2024-fc58da0881d6
Aktenzeichen
RegisterzeichenORD_38807/2024
EntscheidungsreferenzORD_38807/2024
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 5

1 Procedural Order of the Court of First Instance of the Unified Patent Court Local Division Munich issued on 9 August 2024 CLAIMANT Abbott Diabetes Care Inc., 1360 South Loop Road, Alameda, CA 94502, USA, represented by CEO Robert Ford, at the same address, represented by: Attorneys-at-law Dr. Dietrich Kamlah, Dr. Christian Lederer, Dr. Gisbert Hohagen, Taylor Wessing Partnerschaftsgesellschaft mbB , Isartor 8, 80331 Munich, Germany, Patent Attorney Dr. Esslinger, Betten&Resch Partnerschaftsgesellschaft mbB, Maximilianplatz 14, 80333 Munich, Germany. DEFENDANTS 1. Dexcom Inc., 6340 Sequence Drive, CA 92121 San Diego, USA, rrepresented by CEO Kevin Sayer, at the same address, 2. Dexcom Deutschland GmbH, Haifa-Allee 2, 55128 Mainz, Germany, represented by the managing directors Michael Jon  ...